Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04020211 · ClinicalTrials.gov registry record
HF10 Treatment of Chronic Knee Pain
A clinical trial, sponsored by Nevro.
- Terminated
- Registry status
- 3
- Enrollment target
NCT04020211 is a clinical trial that was terminated before completion, run by Nevro. The registered enrollment target is 3 participants.
The verdict
NCT04020211 was terminated before completion, sponsored by Nevro.
- TERMINATED
- Registry status
- 3 participants
- Enrollment target
Study Summary
This is a multi-center study where patients who meet the eligibility criteria will be treated with HF10 therapy for their chronic knee pain post-orthopedic surgery. The primary endpoint will be assessed at 3 months, but observational assessments will continue until study completion at 12 months following implant.
Interventions
- DEVICE Senza HF10 Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-03-14 |
| Est. Completion | 2019-12-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04020211
The ClinicalTrials.gov registry entry for NCT04020211 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nevro, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Senza HF10 Therapy is the first listed.
NCT04020211 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04020211 about?
NCT04020211 is a clinical study titled "HF10 Treatment of Chronic Knee Pain". This is a multi-center study where patients who meet the eligibility criteria will be treated with HF10 therapy for their chronic knee pain post-orthopedic surgery. The primary endpoint will be assessed at 3 months, but observational assessments will continue until study completion at 12 months foll...
What is the current status of trial NCT04020211?
This trial is currently terminated. The enrollment target is 3 participants. The study started on 2019-03-14. Estimated completion is 2019-12-12.
What interventions are being tested in trial NCT04020211?
The interventions under investigation include: Senza HF10 Therapy (DEVICE).
Who is sponsoring clinical trial NCT04020211?
This trial is sponsored by Nevro, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.